We are live on ! Find out more
MCM

McMillion Capital Management Portfolio holdings

AUM $112M
1-Year Est. Return 22.02%
This Fund
S&P 500
This Quarter Est. Return
+0.51%
1 Year Est. Return
+22.02%
3 Year Est. Return
+59.32%
5 Year Est. Return
+93.99%
10 Year Est. Return
+234.06%
AUM
$170M
AUM Growth
-$2.58M
Cap. Flow
-$1.85M
Cap. Flow %
-1.09%
Top 10 Hldgs %
31.33%
Holding
70
New
5
Increased
3
Reduced
51
Closed
2

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$3.46M
2
THC icon
Tenet Healthcare
THC
+$2.74M
3
PNY
PIEDMONT NATURAL GAS CO INC(NC
PNY
+$305K
4
DUK icon
Duke Energy
DUK
+$211K
5
LUMN icon
Lumen
LUMN
+$204K

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$3.8M
2
ABBV icon
AbbVie
ABBV
+$1.49M
3
MMM icon
3M
MMM
+$210K
4
BG icon
Bunge Global
BG
+$192K
5
VZ icon
Verizon
VZ
+$168K

Sector Composition

Rank Sector Weight
1 Technology 17.34%
2 Healthcare 13.63%
3 Industrials 12.68%
4 Energy 11.13%
5 Financials 10.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
51
State Street SPDR S&P 500 ETF Trust
SPY
$822B
$755K 0.44%
3,831
+380
+11% +$75.1K
QQQ icon
52
Invesco QQQ Trust
QQQ
$485B
$585K 0.34%
5,919
+325
+6% +$31.7K
RFG icon
53
Invesco S&P MidCap 400 Pure Growth ETF
RFG
$352M
$527K 0.31%
21,550
– –
NEE icon
54
NextEra Energy
NEE
$181B
$479K 0.28%
20,420
-4,000
-16% -$96.6K
XRT icon
55
State Street SPDR S&P Retail ETF
XRT
$333M
$428K 0.25%
10,000
– –
WIN
56
DELISTED
Windstream Holdings Inc
WIN
$415K 0.24%
4,911
-64
-1% -$5.48K
TEVA icon
57
Teva Pharmaceuticals
TEVA
$40B
$399K 0.23%
7,415
– –
RPG icon
58
Invesco S&P 500 Pure Growth ETF
RPG
$2.11B
$388K 0.23%
25,125
-500
-2% -$7.8K
TGT icon
59
Target
TGT
$67.9B
$353K 0.21%
5,630
-1,000
-15% -$60.6K
T icon
60
AT&T
T
$161B
$350K 0.21%
13,141
-1,721
-12% -$45.8K
PBI icon
61
Pitney Bowes
PBI
$2.54B
$305K 0.18%
12,200
– –
PNY
62
DELISTED
PIEDMONT NATURAL GAS CO INC(NC
PNY
$285K 0.17%
+8,490
New +$305K
IBM icon
63
IBM
IBM
$219B
$237K 0.14%
1,308
– –
DUK icon
64
Duke Energy
DUK
$97.1B
$216K 0.13%
+2,894
New +$211K
DHR icon
65
Danaher
DHR
$138B
$213K 0.13%
4,166
– –
LUMN icon
66
Lumen
LUMN
$7B
$213K 0.13%
+5,202
New +$204K
CL icon
67
Colgate-Palmolive
CL
$73.4B
$206K 0.12%
3,155
– –
FTR
68
DELISTED
Frontier Communications Corp.
FTR
$176K 0.1%
1,800
– –
ABBV icon
69
AbbVie
ABBV
$430B
– –
-26,461
Closed -$1.49M
MRK icon
70
Merck
MRK
$318B
– –
-68,793
Closed -$3.8M
1 2
3

Similar funds

WEPOG
Wealth Enhancement & Preservation of GA Alpharetta, Georgia $104M AUM 15.21% 1-Year Est. Return
SAM
Silverhawk Asset Management Scottsdale, Arizona $122M AUM 10.95% 1-Year Est. Return
MJB
Mark J. Bradley $101M AUM 29.27% 1-Year Est. Return
FNBOSM
First National Bank of South Miami South Miami, Florida $124M AUM 12.26% 1-Year Est. Return
LCM
Linker Capital Management Prospect, Kentucky $97.9M AUM 15.54% 1-Year Est. Return
KCMRT
Kemper Corp Master Retirement Trust Chicago, Illinois $141M AUM 3.25% 1-Year Est. Return
OFG
OTA Financial Group Purchase, New York $143M AUM 16.9% 1-Year Est. Return
AFG
Affinia Financial Group Burlington, Massachusetts $144M AUM 15.67% 1-Year Est. Return

McMillion Capital Management's Q3 2014 Portfolio in Review

As of Q3 2014, McMillion Capital Management held 70 positions worth $170M, down 1.5% from $173M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

McMillion Capital Management's Q3 2014 filing shows 5 new, 3 increased, 51 reduced and 2 closed positions. Its largest new stake was Eli Lilly: 54,715 shares worth $3.55M. The largest sale was Merck, an estimated $3.8M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Industrials.

  • McMillion Capital Management's largest Q3 2014 buy was Eli Lilly: 54,715 shares worth $3.55M.
  • McMillion Capital Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2014, an estimated $75.1K increase.
  • McMillion Capital Management's biggest Q3 2014 reduction was 3M, cutting an estimated $210K.
  • McMillion Capital Management fully exited Merck in Q3 2014, selling an estimated $3.8M.
  • McMillion Capital Management's ten largest holdings make up 31% of its $170M portfolio in Q3 2014.
  • McMillion Capital Management opened 5 new positions and closed 2 in Q3 2014.
  • McMillion Capital Management's portfolio value fell 1.5% quarter-over-quarter to $170M.

Based on McMillion Capital Management's 13F filing for Q3 2014, filed 12 Nov 2014.